Prostate cancer is the most common solid cancer in men and the second leading cause of cancer death in men. A favored treatment option for organ-confined prostate cancer in a middle-aged healthy man is radical prostatectomy (RP). Despite advances in techniques for RP, there remain concerns among physicians and patients alike on its adverse effects on sexual function. Although post-RP erectile dysfunction has been extensively studied, little attention has been focused on the other domains of sexual function, namely loss of libido, ejaculatory dysfunction, orgasmic dysfunction, penile shortening, and Peyronie disease. The aim of this review is to discuss the most recent literature regarding post-RP sexual dysfunctions.
Keyphrases
- radical prostatectomy
- prostate cancer
- middle aged
- papillary thyroid
- oxidative stress
- end stage renal disease
- squamous cell
- mental health
- primary care
- systematic review
- newly diagnosed
- ejection fraction
- chronic kidney disease
- squamous cell carcinoma
- lymph node metastasis
- emergency department
- patient reported outcomes
- young adults
- replacement therapy
- adverse drug
- electronic health record